welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guidelines
source: Journal Of Clinical Oncology
year: 2015
authors: Elena M. Stoffel, Pamela B. Mangu, Stephen B. Gruber, Stanley R. Hamilton, Matthew F. Kalady, Michelle Wan Yee Lau, Karen H. Lu, Nancy Roach, Paul J. Limburg
summary/abstract:Purpose:
To provide recommendations on prevention, screening, genetics, treatment, and management for people at risk for hereditary colorectal cancer (CRC) syndromes. The American Society of Clinical Oncology (ASCO) has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. Methods The Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guideline published in 2013 on behalf of the European Society for Medical Oncology (ESMO) Guidelines Working Group in Annals of Oncology was reviewed for evelopmental rigor by methodologists, with content and recommendations reviewed by an ASCO endorsement panel.
Results:
The ASCO endorsement panel determined that the recommendations of the ESMO guidelines are clear, thorough, and based on the most relevant scientific evidence. The ASCO panel endorsed the ESMO guidelines and added a few qualifying statements. Recommendations Approximately 5% to 6% of patient cases of CRC are associated with germline mutations that confer an inherited predisposition for cancer. The possibility of a hereditary cancer syndrome
should be assessed for every patient at the time of CRC diagnosis. A diagnosis of Lynch syndrome, familial adenomatous polyposis, or another genetic syndrome can influence clinical management for patients with CRC and their family members. Screening for hereditary cancer syndromes in patients with CRC should include review of personal and family histories and testing of tumors for DNA mismatch repair deficiency and/or microsatellite instability. Formal genetic
evaluation is recommended for individuals who meet defined criteria.
read more
expertly curated content related to this topic
-
Familial Adenomatous Polyposis: Mental Health, Psychosocial Functioning and Reactions to Genetic Risk in AdolescentsFamilial adenomatous polyposis (FAP) in ...
-
A Novel Frameshift Mutation in Exon 12 of the Adenomatous Polyposis Coli Gene in an Italian Family with Familial Ade...The adenomatous polyposis coli (APC) gen...
-
APC: The Key to Colon Cancer (The APC Protein and Its Role in Controlling the Cell Cycle)Poster Presentation Abstract: Colorec...
-
Hereditary colorectal cancer family dayhttps://www.youtube.com/watch?v=TZOxfLiT...
-
Messing Up Disorder: How Do Missense Mutations in the Tumor Suppressor Protein APC Lead to Cancer?Mutations in the adenomatous polyposis c...
-
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)A study to evaluate rofecoxib in the tre...
-
The Role of Endoscopy in the Management of Premalignant and Malignant Conditions of the StomachThis is one of a series of statements di...